Table 1 Clinical profile, cardiovascular risk factors and therapies characterizing the subgroup of CAD patients enrolled on the study. Patients have been categorized for the presence of T2DM as a comorbidity

N

15

17

 AGE (years)

65.33 ± 2.41

66.88 ± 2.31

 BMI (KG/m²)

26.86 ± 0.87

27.13 ± 0.79

 Glycemia (mg/dL)

103.1 ± 3.27

137.5 ± 10.31

 LDL (mg/dL)

120.4 ± 11.52

78.40 ± 9.74

 HDL (mg/dL)

48.93 ± 3.58

45.60 ± 3.29

 Total cholesterol (mg/dL)

189.1 ± 12.38

150.0 ± 9.67

 Creatinin(mg/dL)

1.068 ± 0.1

1.096 ± 0.1

 Hypertension

11

15

 Dyslipidemia

11

15

 Smoke

7

6

 Oral antidiabetic agents

0

14

 Insulin

0

1

 Oral antidiabetic agents + Insulin

0

2

 Antihypertensive drugs

12

15

 Lipid-lowering drugs

7

13